Evidence map›Paper›PMID 37091167›Full record

ArticleFrontiers in oncology2023

Impact of deep learning image reconstruction algorithms on CT radiomic features in patients with liver tumors.

Gongbo Xue, Hongyan Liu, Xiaoyi Cai, Zhen Zhang, Shuai Zhang, Ling Liu, Bin Hu, Guohua Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Gongbo XueDepartment of Radiology, Qingdao Municipal Hospital, Qingdao, China.
Hongyan LiuDepartment of Radiology, Qingdao Municipal Hospital, Qingdao, China.
Xiaoyi CaiDepartment of Radiology, Qingdao Municipal Hospital, Qingdao, China.
Zhen ZhangDepartment of Radiology, Qingdao Municipal Hospital, Qingdao, China.
Shuai ZhangCT Imaging Research Center, GE Healthcare China, Shanghai, China.
Ling LiuCT Imaging Research Center, GE Healthcare China, Shanghai, China.
Bin HuDepartment of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Guohua WangDepartment of Radiology, Qingdao Municipal Hospital, Qingdao, China.
Qingdao University · CNDalian Medical University · CNUnited Imaging Healthcare (China) · CNQingdao Municipal Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the impact of deep learning image reconstruction (DLIR) and adaptive statistical iterative reconstruction-Veo (ASIR-V) on abdominal CT radiomic features acquired in portal venous phase in liver tumor patients. Methods: Sixty patients with liver tumors who underwent contrast-enhanced abdominal CT were retrospectively enrolled. Six groups including filtered back projection (FBP), ASIR-V (30%, 70%) and DLIR at low (DLIR-L), medium (DLIR-M and high (DLIR-H), were reconstructed using portal venous phase data. CT-based radiomic features (first-order, texture and wavelet features) were extracted from 2D and 3D liver tumors, peritumor and liver parenchyma. All features were analyzed for comparison. Results: Different reconstruction algorithms influenced most radiomic features. The percentages of first-order, texture and wavelet features without statistical difference among 2D and 3D lesions, peritumor and liver parenchyma for all six groups were 27.78% (5/18), 5.33% (4/75) and 5.56% (1/18), respectively (all Conclusions: Both ASIR-V and DLIR algorithms with different strengths influenced the radiomic features of abdominal CT images in portal venous phase, and the influences aggravated as reconstruction strength increased.

Indexed as

computed tomographydeep learningimage reconstructionlivertexture analysis

Identifiers

PMID37091167
PMCPMC10113560
OpenAlexW4362639529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.